GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Launxp Biomedical Co Ltd (ROCO:6876) » Definitions » Beta

Launxp Biomedical Co (ROCO:6876) Beta : N/A (As of Mar. 30, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Launxp Biomedical Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-03-30), Launxp Biomedical Co's Beta is Not available.


Launxp Biomedical Co Beta Historical Data

The historical data trend for Launxp Biomedical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Launxp Biomedical Co Beta Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beta
- - - -

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beta Get a 7-Day Free Trial - - - - -

Competitive Comparison of Launxp Biomedical Co's Beta

For the Biotechnology subindustry, Launxp Biomedical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Launxp Biomedical Co's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's Beta distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's Beta falls into.


;
;

Launxp Biomedical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Launxp Biomedical Co  (ROCO:6876) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Launxp Biomedical Co Beta Related Terms

Thank you for viewing the detailed overview of Launxp Biomedical Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Launxp Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.

Launxp Biomedical Co Headlines

No Headlines